Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 182

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Anti-integrin monoclonal antibodies

Open access
Byron, Adam, Humphries, Jonathan D., Askari, Janet A., Craig, Sue E., Mould, A. Paul, Humphries, Martin J.·2009·Journal of Cell Science

Abstract

Integrins are a family of 24 heterodimeric transmembrane receptors that support cell-cell and cell-ECM (extracellular matrix) interactions in a multitude of physiological and disease situations (Humphries, 2000; Hynes, 2002). Adhesion that is mediated by integrins is controlled dynamically to allow cell positioning and migration and to prevent abnormal trafficking and anchorage. Integrin signalling in response to ligand binding is achieved by a combination of receptor clustering and conformational changes. Both of these processes can be elicited from the inside of the cell (resulting in the acquisition of a high-affinity receptor conformation and priming of the receptor for ligand binding) and from the outside (to mediate ligand-induced activation and signalling).The study of changes in integrin shape has been greatly aided by the availability of monoclonal antibodies (mAbs) that detect conformation-dependent epitopes. These mAbs have not only helped to pinpoint the intramolecular changes that determine the integrin activation state, but have also proven useful for regulating function. In recent years, major advances have been made in our understanding of the mechanisms that regulate integrin affinity (Arnaout et al., 2005; Luo et al., 2007) and, accordingly, we now also have an improved knowledge of the mechanisms of action of function-regulating mAbs. As these mAbs work in different ways, there is a danger that researchers might select the wrong reagent for their studies and/or misinterpret the data that they obtain. In this Cell Science at a Glance article, we have therefore attempted to explain briefly the mechanisms of antibody regulation of integrins. The accompanying poster lists three classes of key reagents: those that inhibit ligand engagement; those that stimulate ligand engagement or report a high-affinity integrin state (`activation specific'); and those that serve as equally important negative controls. Partly owing to space constraints and partly owing to a lack of available information, we have restricted our selection of mAbs to those that recognise human integrins. Furthermore, we only report mAbs that either affect ligand binding and cell adhesion or, to our knowledge, are non-functional controls. Although we have not catalogued mAbs for use in immunoprecipi tation, immunoblotting, flow cytometry or ELISA-type experiments, many of the reagents listed are suitable for these purposes. The poster is not intended to recommend one mAb in favour of another, but to represent some of the best-characterised examples. The researcher must therefore determine the most appropriate reagent for their specific purpose.The first crystal structure of an integrin (αVβ3) was solved in 2001 (Xiong et al., 2001). The structure revealed a `head' region, which was the main point of contact between the two subunits and comprised a β-propeller fold in the α-subunit and a von Willebrand factor-A domain in the β-subunit (the βA domain). The head was supported by two rod-like `legs'. The α-subunit leg comprised three β-sandwich domains (termed thigh, calf-1 and calf-2) and the β-subunit leg included a PSI (plexin-semaphorin-integrin) domain, an immunoglobulin fold (termed the hybrid domain), four epidermal growth factor (EGF)-like repeats and a cystatin-like fold (termed the β-tail domain). A soluble form of the integrin was used for the crystallisation studies, but it is now well established that both integrin legs link to transmembrane domains and then to short cytoplasmic domains that can interact with each other or with cytoskeletal and signalling proteins (Wegener et al., 2007).Interestingly, the initial crystal structure revealed a bent molecule, with articulation points in both integrin legs at the so-called genu. This form of the integrin is now thought to represent the conformation with low affinity for a ligand. The adoption of a high-affinity conformation involves a series of shape changes, including unbending of the receptor and various inter-module and intra-module movements, such as swing-out of the hybrid domain away from the α-subunit and α-helical movements in the βA domain. Most evidence points to a separation of the cytoplasmic and transmembrane domains as a key step in the acquisition of the high-affinity conformation. It is currently unclear how many classes of integrin conformation exist, but primed and ligand-bound integrins have similar conformations, and these are distinctly different from low-affinity receptors. The poster therefore contains two general representations of integrins (bent and extended). As yet, there are no mAbs that are able to distinguish primed from ligand-bound integrins, although the relative expression of different epitopes varies between these states.Using the prototypic peptide ligand arginine-glycine-aspartate (RGD) in co-crystallisation studies, the ligand-binding pocket in αVβ3 integrin was located at the junction of the β-propeller and the βA domain in the head (X

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1242/jcs.056770

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 182

Metadata

Authors
Byron, A., Humphries, J. D., Askari, J. A., Craig, S. E., Mould, A. P., & Humphries, M. J.
Venue
Journal of Cell Science
Published
2009-11-15
Volume
122
Issue
22
Pages
4009-4011
ISSN
  • 0021-9533 (ISSN-L)
  • 1477-9137
OpenAlex
W2037226238
Cited by
182
References
1
FWCI
6.94
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti-integrin monoclonal antibodies. https://app.cochat.ai/papers/10.1242/jcs.056770
The paper
Byron, A., Humphries, J. D., Askari, J. A., Craig, S. E., Mould, A. P., & Humphries, M. J. (2009). Anti-integrin monoclonal antibodies. Journal of Cell Science. https://doi.org/10.1242/jcs.056770

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.